Lipocine Inc (LPCN)
8.91
+1.17
(+15.12%)
USD |
NASDAQ |
Jun 21, 16:00
8.90
-0.01
(-0.11%)
After-Hours: 20:00
Lipocine Net Income (Annual): -16.35M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.35M |
| December 31, 2022 | -10.76M |
| December 31, 2021 | -0.6344M |
| December 31, 2020 | -20.96M |
| December 31, 2019 | -13.01M |
| December 31, 2018 | -11.66M |
| December 31, 2017 | -20.98M |
| Date | Value |
|---|---|
| December 31, 2016 | -18.97M |
| December 31, 2015 | -18.21M |
| December 31, 2014 | -20.37M |
| December 31, 2013 | -10.59M |
| December 31, 2012 | -0.0767M |
| December 31, 2011 | -0.0052M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-20.96M
Minimum
2020
-0.6344M
Maximum
2021
-12.34M
Average
-13.01M
Median
2019
Net Income (Annual) Benchmarks
| Relmada Therapeutics Inc | -98.79M |
| FibroGen Inc | -284.23M |
| Eliem Therapeutics Inc | -35.12M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -27.54M |